Gasex Extract route tablet in dyspepsia.
- Conditions
- Health Condition 1: null- Dyspepsia
- Registration Number
- CTRI/2012/01/002349
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Cases with symptoms of dyspepsia like indigestion, gaseousness, flatulence, abdominal distension & belching.
Hematologic and Biochemical parameters within normal limits.
Willing to sign inform consent document
Those with serious cardiovascular, cerebrovascular, respiratory, liver or renal disease or any other disorder.
The subjects not to have used any drugs, for at least 1 week prior to the study.
Subjects with a strong history of food or drug allergy of any kind.
Subjects not to have been on weight reducing diets within 3 months prior to the start of the study.
No other drugs (including aspirin) to be ingested during the course of the study.
Patients unwilling to provide informed consent or abide by the requirements of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy of Gasex extract route tablet in comparison with Gasex tablet in patients suffering from DyspepsiaTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method safety profile of gasex extract route tabletTimepoint: At 2 weekly intervals for the period of 4 weeks